GNPX - Genprex, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.7 -0.08 (-11.91%)	0.01 (1.08%)	-0.01 (-2.28%)	-0.01 (-2.28%)	-0.03 (-4.86%)	-0.05 (-7.53%)	-0.19 (-22.0%)	-0.18 (-21.29%)

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Market

Earnings & Ratios

Basic EPS:: -0.17
Diluted EPS:
Basic P/E:: -3.6271
Diluted P/E:
RSI(14) 1m:: 42.26
VWAP:: 0.61
RVol:: 0.6462

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.66 +0.01 (+1.39%)	Oct 16 06:34
1m	Price increase 1m	0.65 +0.01 (+1.1%)	Oct 16 06:32
1m	Price decrease 1m	0.64 -0.01 (-1.57%)	Oct 16 05:33
1m	Price decrease 1m	0.65 -0.01 (-2.12%)	Oct 16 05:20
1m	Price increase 1m	0.66 +0.01 (+1.84%)	Oct 16 05:18